Cargando…
Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease of the central nervous system (CNS), which affects mostly older adults. In recent years, the incidence of PD has been dramatically increasing with the aging population expanding. Due to the lack of effective biomarkers,...
Autores principales: | Shao, Yaping, Le, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330496/ https://www.ncbi.nlm.nih.gov/pubmed/30634989 http://dx.doi.org/10.1186/s13024-018-0304-2 |
Ejemplares similares
-
Recent Advances and Perspectives in Relation to the Metabolomics-Based Study of Diabetic Retinopathy
por: He, Shuling, et al.
Publicado: (2023) -
Recent advances in treating Parkinson’s disease
por: Oertel, Wolfgang H.
Publicado: (2017) -
Recent advances in nonalcoholic fatty liver disease metabolomics
por: Kim, Hwi Young
Publicado: (2021) -
Metabolomics Signatures of Aging: Recent Advances
por: Adav, Sunil S, et al.
Publicado: (2021) -
Recent advances in proteomics and metabolomics in plants
por: Yan, Shijuan, et al.
Publicado: (2022)